Abstract
Supporting Institution
Yok
Project Number
Yok
References
- Khabbaz R, Beth BP, Schuchat A, et al. Emerging and reemerging infectious disease threats. In: Mandel, Dougles, and Bennett’s Principles and Practice of Infectious Disease, Bennett JE, Dolin R, Blaser MJ (eds). 8rd ed. Philadelphia: Elsevier; 2015: 158-77.
- World Health Organization: COVID-19 Weekly Epidemiological Update-24 November 2020. Available at: <https://www.who.int/publications/m/item/weekly-epidemiological-update---24-november-2020> Accessed November 25, 2020.
- Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res 2020; 5: 367–9.
- Shi Y, Yu X, Zhao H, et al. Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan. Crit Care 2020; 1: 2–5.
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Jama 2020; 13: 1239-42.
- Zhai P, Ding Y, Wu X, et al. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents 2020; 5: 105955.
- TR Ministry of Health, General Directorate of Public Health. COVID-19 (SARS-CoV-2 Infection) Treatment of Adult Patients 19 June 2020. Available at: <https://covid19bilgi.saglik.gov.tr/depo/rehberler/covid-19-rehberi/COVID-19_REHBERI_ERISKIN_HASTA_TEDAVISI.pdf>. Accessed July 1, 2020.
- Pan F, Ye T, Sun P. Time course of lung changes at chest ct during recovery from coronavirus disease 2019 (COVID-19). Radiology 2020; 295: 715–21.
- Li K, Wu J, Wu F, et al. The clinical and chest ct features associated with severe and critical COVID-19 pneumonia. Invest Radiol 2020; 6: 327-31.
- China-WHO Expert team . Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available at <https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf >. Accessed by July 1,2020.
- World Health Organization: Clinical Care Severe Acute Respiratory Infection: Tool kit. Available at: < https://apps.who.int/iris/bitstream/handle/10665/331736/WHO-2019-nCoV-SARI_toolkit-2020.1-eng.pdf?sequence=1&isAllowed=y>. Accessed by July 1, 2020.
- Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19) : A literature review. J Infect Public Health 2020; 5: 667–73.
- Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020; 76: 71–6.
- Shi Y, Wang G, Cai XP, et al. An overview of COVID-19. J Zhejiang Univ Sci B 2020; 5: 343–60.
- Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020; 94: 91–5.
- Tufan A, Avanoğlu Güler A, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci 2020; 50: 620–32.
- Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020; 4: 425-34.
- Li R, Tian J, Yang F, et al. Clinical characteristics of 225 patients with COVID-19 in a tertiary hospital near Wuhan, China. J Clin Virol 2020; 127: 104363.
- Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 18: 1708–20.
- Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost 2020; 6: 1324–9.
- Kamps BS, Hoffmann C (editors). Diagnostic Tests and Prosedures. In: COVID reference. Fourth ed., Hamburg: Steinhauser-Verlag; 2020: 155-85.
- World Health Organization: Use of chest imaging in COVID-19. Available at: https://www.who.int/publications/i/item/use-of-chest-imaging-in-covid-19. Accessed by July 1, 2020.
- Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A systematic review of ımaging findings in 919 patients. AJR Am J Roentgenol 2020; 1: 87–93.
- Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020; 3: 105924.
- Song F, Shi N, Shan F, et al. Emerging 2019 novel coronavirus (2019-NCoV) pneumonia. Radiology 2020; 1: 210–7.
The impact and relationship of inflammatory markers and radiologic involvement in the COVID-19 patients
Abstract
Aim: In the study, it was aimed to investigate the relationship between inflammatory markers and radiology in COVID-19 patients.
Material and Method: The study was conducted in the quarantine wards of a tertiary hospital between March and June 2020. Patients with a definite diagnosis of COVID-19 were included in the study. The lung damage of the patients caused by COVID-19 was determined by computed tomography and the relationship between lung damage and inflammatory markers was examined.
Results: The mean age of 259 COVID-19 patients included in the study was 61.96 ± 14.076. Except for thrombocytopenia, all variables such as ferritin, D-dimer, thoracic computerized tomography (CT) involvement rates were significantly poorer in the patients requiring the care in ICU than the patients in wards (p<0.001). No chronic disease was found in 193 (74.5%) of 259 patients. In multi-variate analyzes, elderly and high thoracic CT involvement rate were determined as independent variables determining the serious disease risks and are important parameters in assessing the need for ICU (p<0.05). Ferritin value, D-Dimer value on the third day of admission, Neutrophil lymphocyte ratio and leukocyte count were found to be correlated with thoracic CT involvement rate (p <0.05).
Conclusion: It was observed that there were serious changes in the infection parameters of COVID-19 cases with advanced radiological involvement in the lung.
Keywords
Project Number
Yok
References
- Khabbaz R, Beth BP, Schuchat A, et al. Emerging and reemerging infectious disease threats. In: Mandel, Dougles, and Bennett’s Principles and Practice of Infectious Disease, Bennett JE, Dolin R, Blaser MJ (eds). 8rd ed. Philadelphia: Elsevier; 2015: 158-77.
- World Health Organization: COVID-19 Weekly Epidemiological Update-24 November 2020. Available at: <https://www.who.int/publications/m/item/weekly-epidemiological-update---24-november-2020> Accessed November 25, 2020.
- Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res 2020; 5: 367–9.
- Shi Y, Yu X, Zhao H, et al. Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan. Crit Care 2020; 1: 2–5.
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Jama 2020; 13: 1239-42.
- Zhai P, Ding Y, Wu X, et al. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents 2020; 5: 105955.
- TR Ministry of Health, General Directorate of Public Health. COVID-19 (SARS-CoV-2 Infection) Treatment of Adult Patients 19 June 2020. Available at: <https://covid19bilgi.saglik.gov.tr/depo/rehberler/covid-19-rehberi/COVID-19_REHBERI_ERISKIN_HASTA_TEDAVISI.pdf>. Accessed July 1, 2020.
- Pan F, Ye T, Sun P. Time course of lung changes at chest ct during recovery from coronavirus disease 2019 (COVID-19). Radiology 2020; 295: 715–21.
- Li K, Wu J, Wu F, et al. The clinical and chest ct features associated with severe and critical COVID-19 pneumonia. Invest Radiol 2020; 6: 327-31.
- China-WHO Expert team . Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available at <https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf >. Accessed by July 1,2020.
- World Health Organization: Clinical Care Severe Acute Respiratory Infection: Tool kit. Available at: < https://apps.who.int/iris/bitstream/handle/10665/331736/WHO-2019-nCoV-SARI_toolkit-2020.1-eng.pdf?sequence=1&isAllowed=y>. Accessed by July 1, 2020.
- Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19) : A literature review. J Infect Public Health 2020; 5: 667–73.
- Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020; 76: 71–6.
- Shi Y, Wang G, Cai XP, et al. An overview of COVID-19. J Zhejiang Univ Sci B 2020; 5: 343–60.
- Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020; 94: 91–5.
- Tufan A, Avanoğlu Güler A, Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk J Med Sci 2020; 50: 620–32.
- Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis 2020; 4: 425-34.
- Li R, Tian J, Yang F, et al. Clinical characteristics of 225 patients with COVID-19 in a tertiary hospital near Wuhan, China. J Clin Virol 2020; 127: 104363.
- Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 18: 1708–20.
- Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost 2020; 6: 1324–9.
- Kamps BS, Hoffmann C (editors). Diagnostic Tests and Prosedures. In: COVID reference. Fourth ed., Hamburg: Steinhauser-Verlag; 2020: 155-85.
- World Health Organization: Use of chest imaging in COVID-19. Available at: https://www.who.int/publications/i/item/use-of-chest-imaging-in-covid-19. Accessed by July 1, 2020.
- Salehi S, Abedi A, Balakrishnan S, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19): A systematic review of ımaging findings in 919 patients. AJR Am J Roentgenol 2020; 1: 87–93.
- Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020; 3: 105924.
- Song F, Shi N, Shan F, et al. Emerging 2019 novel coronavirus (2019-NCoV) pneumonia. Radiology 2020; 1: 210–7.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Original Article |
| Authors | |
| Project Number | Yok |
| Publication Date | July 15, 2021 |
| Published in Issue | Year 2021 Volume: 4 Issue: 4 |
Cited By
The relationship between thoracic CT findings and C-reactive protein and ferritin levels in COVID-19 patients
Journal of Health Sciences and Medicine
https://doi.org/10.32322/jhsm.1258459
The comparison of chest X-ray and CT visibility according to size and lesion types in the patients with COVID-19
Journal of Health Sciences and Medicine
https://doi.org/10.32322/jhsm.1100231
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
|
|
|
| |
|
|
|
|
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
|
|
|
|
|
|
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.